PHARMACOGENOMICS

Publications

  1. 2016
  2. Nucleotide excision repair and response and survival to chemotherapy in colorectal cancer patients

    Kap, E. J., Popanda, O. & Chang-Claude, J., 05.2016, In: PHARMACOGENOMICS. 17, 7, p. 755-94 40 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  3. Potential of circulating tumor cells as blood-based biomarkers in cancer liquid biopsy

    Schlange, T. & Pantel, K., 02.2016, In: PHARMACOGENOMICS. 17, 3, p. 183-6 4 p.

    Research output: SCORING: Contribution to journalOther (editorial matter etc.)Research

  4. 2013
  5. A frequent gene polymorphism affecting the heart-rate response to carvedilol

    Eschenhagen, T., 01.01.2013, In: PHARMACOGENOMICS. 14, 2, p. 115-8 4 p.

    Research output: SCORING: Contribution to journalOther (editorial matter etc.)Research

  6. 2009
  7. Human formyl peptide receptor 1 (FPR1) c.32C>T SNP is associated with decreased soluble E-selectin levels

    Benachour, H., Zaiou, M., Herbeth, B., Lambert, D., Lamont, J. V., Pfister, M., Siest, G., Tiret, L., Blankenberg, S., Fitzgerald, P. S. & Visvikis-Siest, S., 06.2009, In: PHARMACOGENOMICS. 10, 6, p. 951-959 9 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review